摘要:
A method for preparing 2-amino-β-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-β-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino β-lactam with a more desirable protecting group.
摘要:
There is described a process for the preparation of a compound of the formula I A process for the preparation of a compound of the formula I which comprises reacting at least about 0.1 mole of triethylamine and at least about 0.1 mole of chlorotrimethylsilane per mole of 6β-acylaminopenicillin- 1β-sulfoxide compound of the following formula (II) in a substantially anhydrous ether or hydrocarbon solvent, in which solvent the above 6β-acyhaminopenicillin-1β-sulfoxide (II) is present in a concentration of about 0.7 molar or greater, in a substantially anhydrous atmosphere at a temperature between about -20°C and about 20°C where in the above formulas R 1 is hydrogen or an acyl group derived from a carboxylic acid; and R 2 is an acyl group derived from a carboxylic acid; or R 1 and R 2 taken together with the nitrogen atom to which they are attached form a group of the formula wherein R 4 is the residue of an acyl group derived from a dicarboxylic acid; and R 3 is hydrogen or a conventional carboxylic acid protecting group.
摘要:
A halogenating compound is described of the general formula which is the kinetically controlled product of the reaction of equivalent amounts of a triaryl phosphite of the formula and chlorine or bromine in a substantially anhydrous inert organic solvent wherein in the above formulas Z is hydrogen, halo, C 1 -C 4 alkyl or C 1 -C 4 alkoxy, and X is Cl or Br.
摘要:
The invention provides a gene encoding a novel PBP2A penicillin binding protein isolated from the methicillin resistant S . aureus strain 27R. The invention further provides soluble forms of PBP2A proteins lacking the transmembrane association region yet retain their active site configuration of the PBP2A protein. The invention also provides a method of assaying for agents useful against methicillin resistant staphylococcus strains by creating a kinetically inert complex between a support-immobilized transition metal ion and a modified soluble form of the PBP2A protein incorporating a chelating agent. The invention further provides a cell free method of assaying for agents which bind the PBP2A-27R protein.
摘要:
Kinetically controlled triaryl phosphite halogen compounds of the formula wherein X is Cl or Br, and Z is hydrogen, halo, C 1 -C 4 alkyl or C 1 -C 4 alkoxy, are used to effect
a) halogenation of a C-6 or C-7 acylamine penicillin or cephalosporin, b) halogenation of a 3-hydroxy-3-cephem, c) one step halogenation of a C-7 acylamine-3-hydroxy- cephem d) reduction of a cephalosporin sulfoxide e) one step reduction/halogenation of a 3-hydroxy cephalosporin sulfoxide f) one step reduction/halogenation of a C-7 acylamine cephalosporin sulfoxide g) one step reduction/halogenation of a C-7 acylamino-3-hydroxy cephalosporin sulfoxide.
摘要:
The invention provides a gene encoding a novel PBP2A penicillin binding protein isolated from the methicillin resistant S. aureus strain 27R. The invention further provides soluble forms of PBP2A proteins lacking the transmembrane association region yet retain their active site configuration of the PBP2A protein. The invention also provides a method of assaying for agents useful against methicillin resistant staphylococcus strains by creating a kinetically inert complex between a support-mobilized transition metal ion and a modified soluble form of the PBP2A protein incorporating a chelating agent. The invention further provides a cell free method of assaying for agents which bind the PBP2A-27R protein.
摘要:
The invention provides a free radical process for preparing 1-carba(1-dethia)cephalosporin antibiotics with 2-substituted methylcephalosporin 1,1-dioxides wherein the substituent on the 2-methylene group is a free radical precursor group such as a phenyl or alkylseleno group. The latter dioxides are treated with a free radical initiator, e.g., a trialkyltin hydride or actinic radiation at 40°C to 150°C to provide the 1-carba-3-cephem and 1-carba-2-cephem products. The invention also provides free radical compounds formed as intermediates in the process.
摘要:
7-(3-Benzothienyl)glycylamido cephalosporins provided by this invention possess favorable pharmacokinetics and are orally-effective against gram positive microorganisms.
摘要:
7-(3-Indolyl)glycylamido cephalaosporins provided by this invention possess favorable pharmocokinetics and are orally effective against gram positive microorganisms.